• % CD4 CMV Interferon-gamma Cells
• % CD8 CMV Interferon-gamma Cells
• % CD4 SEB Interferon-gamma Cells
• % CD8 SEB Interferon-gamma Cells
• Viability

The CMV inSIGHT™ T Cell Immunity Panel measures the strength of T cell responses to Cytomegalovirus (CMV) specific antigens. It evaluates and reports the activity of CD4 and CD8 T cell responses independently. Effective T cell immunity against CMV is a factor in controlling CMV viral latency. CMV can affect patients with weakened immune systems and is a common risk factor in patients following solid organ or hematopoietic stem cell transplant.

Specimen Type: Whole Blood

Collection Container: Green Top (Sodium Heparin)

Desired Specimen Volume: 6 mL

Cell Function Testing requires special attention to specimen collection and shipping in order to ensure the integrity of the sample. Testing is by appointment only

1. Collect a green top (sodium heparin) tube via venipuncture between 8 a.m - 12 p.m Monday - Thursday only.
2. Tube must be at least ¾ full (4.5 mL) to maintain proper ratio of blood to anticoagulant.
3. Maintain specimen at room temperature and protect against cold drafts.
4. DO NOT collect on days when a holiday follows within 2 days of the collection day.

1. A scheduled courier is required for specimen transport
2. Label specimen with a room temperature sticker.
3. Transport 6 mL of whole blood in the original collection container at room temperature. Do not refrigerate or freeze.

Transport to the laboratory at room temperature.

• Whole blood received after stability (32 hours after collection)
• Whole blood received cold or frozen
• Tubes received less than 3/4 full
• Specimens received in lithium heparin, ACD tubes or EDTA anticoagulants

See patient report.